SMTL ID : 8fv3.2 (1 other biounit)

EGFR(T790M/V948R) in complex with compound 1 (LN4503)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

homo-dimer

Ligands

1 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 4 residues within 4Å: Chain A: K.51, N.148, D.161 Ligands: ANP.2 2 PLIP interactions: 1 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.161, H2O.1

1 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)

ANP.2: 20 residues within 4Å: Chain A: G.25, S.26, G.27, A.28, F.29, G.30, V.32, A.49, K.51, M.96, Q.97, L.98, M.99, C.103, D.143, R.147, N.148, L.150, D.161 Ligands: MG.1 12 PLIP interactions: 12 interactions with chain A Hydrogen bonds: A:A.28, A:F.29, A:K.51, A:Q.97, A:M.99, A:C.103, A:R.147, A:N.148 Water bridges: A:G.30, A:K.51, A:D.106 Salt bridges: A:K.51

1 x YA6: N-{(4P)-4-[(4P)-5-{3-[(8-fluoro-11-oxo-5,11-dihydro-10H-dibenzo[b,e][1,4]diazepin-10-yl)methyl]phenyl}-2-(methylsulfanyl)-1H-imidazol-4-yl]pyridin-2-yl}acetamide(Non-covalent)

YA6.3: 23 residues within 4Å: Chain B: L.24, G.27, V.32, A.49, I.50, K.51, M.72, C.81, R.82, L.83, L.94, M.96, Q.97, L.98, M.99, P.100, G.102, L.150, T.160, D.161, F.162, G.163, L.164 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:A.49, B:K.51, B:L.150, B:D.161, B:L.164 Hydrogen bonds: B:K.51, B:K.51, B:M.99, B:M.99 pi-Stacking: B:F.162

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wittlinger, F. et al., Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors. Commun Chem (2024)

Release Date

2024-01-17

Peptides

Epidermal growth factor receptor: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
C

Epidermal growth factor receptor

Related Entries With Identical Sequence